14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for KRYS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 165.33 3.54 %
R2 162.27 1.63 %
R1 160.39 0.448 %
Current price: 159.67
Support S1 154.27 -3.38 %
S2 152.39 -4.56 %
S3 149.33 -6.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 171.84 7.62 %
R2 170.84 7.00 %
R1 170.15 6.56 %
Current price 159.67
Support S1 159.47 -0.125%
S2 157.25 -1.52%
S3 157.00 -1.67%

KRYS Predictions History

3 days ago
PredictionBot.Warren predicted that KRYS for Apr. 29th is going $158.50 (0.32%)

6 days ago
goynesq.236280 predicted that KRYS for Apr. 29th is going

11 months ago
PredictionBot.Kathy predicted that KRYS for 2023-05-25 is going $116.38 (-0.86%)

11 months ago
PredictionBot.Warren predicted that KRYS for 2023-05-25 is going $117.19 (-0.17%)

11 months ago
MikeH predicted that KRYS for 2023-05-25 is going

Rank:

4 years ago
PumpTheseNumbers predicted that KRYS for 2019-12-03 is going $60.17 (0.96%)

4 years ago
Eric.Guimbeau.105442 predicted that KRYS for 2019-12-03 is going

Rank:

4 years ago
JS predicted that KRYS for 2019-07-08 is going $44.34 (4.87%)

4 years ago
GoldenNugget predicted that KRYS for 2019-05-07 is going $30.60 (-3.06%)

4 years ago
GoldenNugget predicted that KRYS for 2019-05-06 is going $30.97 (-1.27%)

Click to get the best stock tips daily for free!

About Krystal Biotech Inc

Krystal Biotech Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con... KRYS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT